Teynofor 245 mg filmom obložene tablete
| Name | Teynofor 245 mg filmom obložene tablete |
|---|---|
| Former Name | Tenofovirdizoproksil Alpha-Medical 245 mg filmom obložene tablete |
| Marketing Authorisation Number | HR-H-529695861 |
| Active Substance | tenofovirdizoproksilsukcinat |
| Composition | jedna filmom obložena tableta sadrži 245 mg tenofovirdizoproksila (u obliku tenofovirdizoproksilsukcinata) |
| Pharmaceutical Form | filmom obložena tableta |
| Packaging [MA Number for Packaging] | 30 tableta u bočici, u kutiji [HR-H-529695861-01] 90 tableta (3 bočice sa po 30 tableta u kutiji) omotane folijom [HR-H-529695861-02] |
| Manufacturer | Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date | 23.10.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/47 |
| Registration Number | 381-12-01/70-23-20 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | J05AF07 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
